Skip Navigation


Mol. Hum. Reprod. Advance Access originally published online on August 11, 2009
Molecular Human Reproduction 2009 15(10):633-643; doi:10.1093/molehr/gap063
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
15/10/633    most recent
gap063v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Mönckedieck, V.
Right arrow Articles by Grümmer, R.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mönckedieck, V.
Right arrow Articles by Grümmer, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

This article appears in the following Molecular Human Reproduction issue: Special Issue: Mechanisms of Endometriosis [View the issue table of contents]

Progestins inhibit expression of MMPs and of angiogenic factors in human ectopic endometrial lesions in a mouse model

Verena Mönckedieck1, Carolin Sannecke1, Bettina Husen2, Michael Kumbartski3, Rainer Kimmig3, Martin Tötsch4, Elke Winterhager1 and Ruth Grümmer1,5

1Institute of Molecular Biology, University Hospital Essen, 45122 Essen, Germany 2Solvay Pharmaceuticals Research Laboratories, 30173 Hannover, Germany 3Department of Gynecology, University Hospital Essen, 45122 Essen, Germany 4Institute of Pathology and Neuropathology, University Hospital Essen, 45122 Essen, Germany

5 Correspondence address: Tel: +49-201-7231636; Fax: +49-201-7235974; E-mail: ruth.gruemmer{at}uk-essen.de

Progestins are successfully used in the treatment of endometriosis; however, the exact mechanisms of their action are still unsolved. We here focused on the effect of different progestins on parameters of extracellular matrix degradation and angiogenesis involved in the establishment and maintenance of ectopic endometrial lesions. Human endometrium was intraperitoneally transplanted into nude mice. After 7 and 28 days of treatment with progesterone, dydrogesterone, or its metabolite dihydrodydrogesterone, respectively, ectopic lesions were evaluated for proliferation and apoptosis. Expression of estrogen receptor {alpha}, progesterone receptor-AB, the angiogenetic factors, cysteine-rich angiogenic inducer (CYR61), basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGFA) and the matrix metalloproteinase (MMP)-2, -3, -7 and -9 was investigated. Functional impact on angiogenesis was evaluated by density of microvessels and of vessels stabilized by pericytes within the ectopic lesions. Although dydrogesterone significantly reduced proliferation of endometrial stromal cells after 28 days, suppression of apoptosis was independent from progestins. Expression of MMP-2 was significantly reduced by all progestins and MMP-3 by dydrogesterone. In the grafted endometrial tissue, transcription of bFGF was suppressed by progesterone and dihydrodydrogesterone, and VEGFA and CYR61 by dihydrodydrogesterone and dydrogesterone. In parallel, microvessel density was slightly suppressed by progestins, whereas number of stabilized vessels increased. Thus, progestins regulate factors important for the establishment and maintenance of ectopic endometrial lesions.

Key words: progestins/dydrogesterone/MMP/angiogenesis/endometriosis

Submitted on May 4, 2009; resubmitted on July 27, 2009; accepted on July 29, 2009.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.